GlassScriptPhysician profile
Ahmed Abdalla
NPI 1730758285
$2,176.97
in general payments reported to CMS, 2019-2025
10 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $857 · 2023: $405 · 2024: $372 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $721.05 | 2021-2025 | Ams 700, Spaceoar Vue System - 10ml, Lithoclast |
| Medtronic, INC. | $404.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $396.69 | 2022-2025 | Imfinzi |
| Teleflex LLC | $271.15 | 2022-2024 | Urolift |
| Janssen Scientific Affairs, LLC | $151.87 | 2024-2025 | Erleada |
| Astellas Pharma Global Development | $86.39 | 2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $76.94 | 2023 | Prolaris |
| Janssen Biotech, INC. | $25.33 | 2024 | Erleada |
| Novartis Pharmaceuticals Corporation | $23.95 | 2025 | |
| Endo USA, INC. | $19.26 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Abdalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.